Related Experiment Video
Updated: Mar 1, 2026
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Heterogeneity in renal cell carcinoma
Alp Tuna Beksac1, David J Paulucci1, Kyle A Blum1
1Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.
Introduction:
In recent years, molecular characterization of renal cell carcinoma has facilitated the identification of driver genes, specific molecular pathways, and characterization of the tumor microenvironment, which has led to a better understanding of the disease. This comprehension has revolutionized the treatment for patients with metastatic disease, but despite these advancements many patients will develop resistance leading to treatment failure. A primary cause of this resistance and subsequent treatment failure is tumor heterogeneity. We reviewed the literature on the mechanisms of tumor heterogeneity and its clinical implications.
Methods:
A comprehensive literature search was performed using the MEDLINE/PubMed Index.
Results:
Intertumor and intratumor heterogeneity is possibly a reason for treatment failure and development of resistance. Specifically, the genetic profile of a renal tumor differs spatially within a tumor as well as among patients. Genomic mutations can change temporally with resistant subclones becoming dominant over time.
Conclusions:
Accounting for intratumor and intertumor heterogeneity with better sampling of cancer tissue is needed. This will hopefully lead to improved identification of driver mutations and actionable targets. Only then, we can move past the one-size-fits-all approach toward personalized treatment based on each individual׳s molecular profile.
Insights
Tumor heterogeneity in renal cell carcinoma drives treatment resistance. Understanding intertumor and intratumor genetic differences is crucial for developing personalized therapies and overcoming treatment failure.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Molecular characterization of renal cell carcinoma (RCC) has improved understanding of driver genes, pathways, and the tumor microenvironment.
- Advancements in molecular profiling have revolutionized metastatic RCC treatment, yet treatment resistance remains a significant challenge.
- Tumor heterogeneity is a primary driver of resistance and subsequent treatment failure in RCC.
Purpose of the Study:
- To review the literature on the mechanisms of tumor heterogeneity in renal cell carcinoma.
- To explore the clinical implications of tumor heterogeneity in RCC treatment resistance.
Main Methods:
- A comprehensive literature search was conducted using the MEDLINE/PubMed Index.
Main Results:
- Intertumor and intratumor heterogeneity contribute to treatment failure and resistance in RCC.
- Genetic profiles of renal tumors exhibit spatial differences within tumors and variations among patients.
- Genomic mutations can change over time, leading to the dominance of resistant subclones.
Conclusions:
- Improved tissue sampling is needed to account for intratumor and intertumor heterogeneity.
- Better understanding of heterogeneity will enhance the identification of driver mutations and actionable targets.
- Personalized treatment strategies based on individual molecular profiles are essential to move beyond one-size-fits-all approaches.
More Related Videos
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
02:38The Ras Gene
Ras is a...
01:24Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...